![Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk](https://www.ahajournals.org/cms/asset/7bec410e-c520-40c2-89c4-c06d4349106e/e003476fig03.jpg)
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk
![EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update - EuroIntervention EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update - EuroIntervention](https://files.eurointervention.com/issues/EIJ164/212_EIJY19M08_01_Glikson_164/images/tab02_Glikson_LAAO2019.jpg)
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update - EuroIntervention
![Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study | The BMJ Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study | The BMJ](https://www.bmj.com/content/bmj/342/bmj.d124/F1.large.jpg)
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study | The BMJ
![Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk](https://www.ahajournals.org/cms/asset/d0d191e0-987d-42cc-983f-d06e4fcdb336/e003476fig02.jpg)